EGFR and cancer prognosis.
暂无分享,去创建一个
R. Nicholson | J. Gee | M. Harper | J. Gee | R I Nicholson | J M Gee | M E Harper
[1] L. Hennighausen,et al. Transforming growth factor alpha and mouse models of human breast cancer , 2000, Oncogene.
[2] M. J. van de Vijver,et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] S. Kitano,et al. Immunohistochemical Study of c-erbB-2 Protein in Colorectal Cancer and the Correlation with Patient Survival , 1998, Oncology.
[4] A. Tokunaga,et al. Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer. , 1998, Nihon Ika Daigaku zasshi.
[5] J. Koudstaal,et al. Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors , 1998 .
[6] Y. Yamashita,et al. Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers. , 1998, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[7] Hiroshi Yamamoto,et al. Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features , 1998, Oncology.
[8] A. Lenferink,et al. Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.
[9] S. Ranga,et al. Comparative evaluation of cell proliferative indices and epidermal growth factor receptor expression in gastric carcinoma. , 1997, Indian journal of pathology & microbiology.
[10] K. Pavelić,et al. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. , 1997, Gastroenterology.
[11] R. Nicholson,et al. erbB Signalling and Endocrine Sensitivity of Human Breast Cancer , 1997 .
[12] H. Heinzl,et al. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. , 1997, Anticancer research.
[13] G. Paludetti,et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. , 1996, British Journal of Cancer.
[14] T. Yoshizaki,et al. Prognostic Value of EGFR and TGF‐α in Early Laryngeal Cancer Treated With Radiotherapy , 1996 .
[15] A. Yang,et al. [The role of endoscopic ultrasonography and epidermal growth factor receptor assay in preoperative staging for gastric carcinoma]. , 1995, Zhonghua nei ke za zhi.
[16] H. Sasano,et al. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. , 1995, Human pathology.
[17] N. Normanno,et al. Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.
[18] T. Okuda,et al. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c‐erbb‐2 in human gastric cancer , 1995, Cancer.
[19] D. Neal,et al. Original Articles: Bladder Cancer , 1995 .
[20] M. Leader,et al. Cytoplasmic c‐erbB‐2 protein expression correlates with survival in Dukes' B colorectal carcinoma , 1994, Histopathology.
[21] Henson Sw,et al. Clinical study on epidermal growth factor and its receptor in human gastric cancer , 1994 .
[22] I. Ellis,et al. Transforming Growth Factor-α and Endocrine Sensitivity in Breast Cancer , 1994 .
[23] H. Kawamata,et al. In vitro and in vivo accelertration of the neoplastic phenotype of a low‐tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor‐α , 1994 .
[24] K. Sugimachi,et al. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. , 1994, Surgical oncology.
[25] H. Ludwig,et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer , 1993, Cancer.
[26] N. Quenville,et al. Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. , 1992, Surgical oncology.
[27] J G Klijn,et al. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.
[28] H. Takamura,et al. Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. , 1992, Oncology.
[29] K. Takemura,et al. [Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas]. , 1991, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.
[30] R. Steele,et al. Epidermal growth factor receptor expression in colorectal cancer , 1990, The British journal of surgery.
[31] K. Sugimachi,et al. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. , 1990, Cancer research.
[32] Atsushi Ochiai,et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma , 1988, International journal of cancer.
[33] Atsushi Ochiai,et al. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. , 1988, Cancer research.
[34] A. Ullrich,et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.